(Q47627313)

4 February 2018

title

Salvage chemotherapy with mini-BEAM for relapsed or refractory non-Hodgkin's lymphoma prior to autologous bone marrow transplantation (English)

1 reference

4 February 2018

1 reference

C Girouard

1

1 reference

4 February 2018

J Dufresne

2

1 reference

4 February 2018

K Imrie

3

1 reference

4 February 2018

A K Stewart

4

1 reference

4 February 2018

J Brandwein

5

1 reference

4 February 2018

H M Prince

6

1 reference

4 February 2018

D Pantolony

7

1 reference

4 February 2018

A Keating

8

1 reference

4 February 2018

M Crump

9

1 reference

4 February 2018

publication date

1 July 1997

1 reference

4 February 2018

published in

Annals of Oncology

1 reference

4 February 2018

volume

8

1 reference

4 February 2018

issue

7

1 reference

4 February 2018

page(s)

675-680

1 reference

4 February 2018

EPOCH chemotherapy: toxicity and efficacy in relapsed and refractory non-Hodgkin's lymphoma.

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008294725992

7 January 2021

Results of MIME salvage regimen for recurrent or refractory lymphoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008294725992

7 January 2021

High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008294725992

7 January 2021

Bone marrow transplantation prolongs survival after relapse in aggressive-lymphoma patients treated with the LNH-84 regimen

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008294725992

7 January 2021

High-dose therapy and autologous bone marrow transplantation in partial remission after first-line induction therapy for diffuse non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008294725992

7 January 2021

The role of autologous bone marrow transplantation in 46 adult patients with non-Hodgkin's lymphomas

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008294725992

7 January 2021

Treatment of relapsed non-Hodgkin's lymphomas with dexamethasone, high-dose cytarabine, and cisplatin before marrow transplantation

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008294725992

7 January 2021

High-dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008294725992

7 January 2021

One hundred autotransplants for relapsed or refractory Hodgkin's disease and lymphoma: value of pretransplant disease status for predicting outcome

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008294725992

7 January 2021

Factors affecting the outcome of autologous bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008294725992

7 January 2021

Treatment of patients with relapsed and resistant non-Hodgkin's lymphoma using total body irradiation, etoposide, and cyclophosphamide and autologous bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008294725992

7 January 2021

NOPE for relapsed aggressive diffuse non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008294725992

7 January 2021

ESHAP--an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008294725992

7 January 2021

Mini-beam as salvage chemotherapy for refractory Hodgkin's disease and non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008294725992

7 January 2021

DICE (dexamethasone, ifosfamide, cisplatin, etoposide) as salvage therapy in non-Hodgkin's lymphomas

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008294725992

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008294725992

7 January 2021

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008294725992

7 January 2021

Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008294725992

7 January 2021

The role of intensive therapy and autologous blood and marrow transplantation for chemotherapy-sensitive relapsed and primary refractory non-Hodgkin's lymphoma: identification of major prognostic groups.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008294725992

7 January 2021

Phase II study of paclitaxel in relapsed non-Hodgkin's lymphomas

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008294725992

7 January 2021

Identifiers

DOI

10.1023/A:1008294725992

1 reference

4 February 2018

Dimensions Publication ID

1000992968

0 references

1 reference

4 February 2018